Drug
Albuvirtide clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 1
- first study started
- 2014
How studies write it
Studies that test it under each name
Name
- ABT
- 4
Studies by the year they started
6 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 1
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Frontier Biotechnologies Inc. (5) · Shanghai Public Health Clinical Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses albuvirtide is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous InjectionCompletedPhase 1Frontier Biotechnologies Inc.NCT05206019Written as Albuvirtide
- Test Albuvirtide in Experienced PatientsCompletedPhase 3Frontier Biotechnologies Inc.NCT02369965Written as albuvirtide
- Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 InfectionStatus unknownPhase 2Frontier Biotechnologies Inc.NCT04560569Written as Albuvirtide
- Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed SubjectsStatus unknownPhase 2Frontier Biotechnologies Inc.NCT03719664Written as Albuvirtide
- The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult SubjectsCompletedPhase 4Shanghai Public Health Clinical CenterNCT04006353Written as ABT
- Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 InfectionStatus unknownPhase 2Frontier Biotechnologies Inc.NCT04819347Written as Albuvirtide
Given in every arm · 1 — albuvirtide is usual care beside what is tested
Codes
What other systems call albuvirtide · ClinicalTrials.gg INT006089
- MeSH (NLM) C573334albuvirtideOne source NLM
- UNII (FDA) MG9PC54E43LABUVIRTIDEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C573334 | albuvirtide | One source NLM |
| UNII (FDA) | MG9PC54E43 | LABUVIRTIDE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.